Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that the most important drug attributes surveyed infectious disease specialists seek in a drug to treat severe Candida infections in the hospital setting are activity against Candida albicans and non-albicans species and fungicidal activity. Candida albicans is the most common species involved in these invasive fungal infections, but the prevalence of non-albicans species has been rising. read more »
The U.S. Food and Drug Administration is warning consumers in Puerto Rico that two hand sanitizers – "Bee-Shield Hand Sanitizer” with Aloe Vera (10 fl. oz. or 1 gallon bottles) and “MD Quality Hand Sanitizer” with Aloe Vera (10 fl oz. bottles) – contain high levels of a bacteria, Burkholderia cepacia, that can cause serious infections in humans. read more »
Dr. Robert B. Arnot has released a white paper entitled "Touch Surfaces: The Silent Threat," the result of months of comprehensive research which warns that in the current worldwide H1N1 pandemic, hard surfaces are emerging as a key source of bacterial and viral infections. Dr. Arnot, a nationally recognized TV medical correspondent and Chief Medical Educator of touchsurfaces.org, also offers infection-prevention recommendations, including hand washing, sanitizers, and a new EPA-approved low-toxicity, long-lasting disinfectant called SpectraSan 24. read more »
Econo-Keys, a leader in washable medical peripherals, has redesigned its most popular waterproof keyboard for higher backlight efficiency. read more »
MRSA Survivors Network, the nonprofit and official organization for World MRSA Day has announced the theme for 2010: "The MRSA Epidemic- A Call to Action." This theme was chosen to raise awareness for MRSA and draw attention to the dire need for an immediate response to the growing global threat, www.worldmrsaday.org. read more »
MRSA Survivors Network, the nonprofit and official organization for World MRSA Day has announced the theme for 2010: "The MRSA Epidemic- A Call to Action." This theme was chosen to raise awareness for MRSA and draw attention to the dire need for an immediate response to the growing global threat, www.worldmrsaday.org. read more »
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that delays in the U.S. approval and launch of Theravance/Astellas's Vibativ (telavancin) for the treatment of nosocomial pneumonia will reduce by more than half the commercial impact that it was previously forecasted to garner in the methicillin-resistant Staphylococcus aureus (MRSA) drug market. read more »
The Sani-Bag+ significantly reduces the potential for transmission of harmful bacteria and spores from human waste to caregivers and patients. Results from an independent laboratory study found that the Sani-Bag+ demonstrates ≥99.99% microbial barrier performance and is an effective microbial barrier. read more »
MedaSorb Technologies Corporation and its wholly-owned subsidiary, CytoSorbents, Inc., announced that it was approved to participate, for its second year, in the New Jersey Emerging Technology and Biotechnology Financial Assistance Program. CytoSorbents was approved by the State to sell additional net operating losses, which has resulted in net proceeds of approximately $299,000 to the Company. read more »
WM Healthcare Solutions', a subsidiary of Waste Management, extensive mail-back sharps product line is now approved by the California Department of Public Health for sale and use in the state of California. read more »